Delin Q. Liu
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100730, China
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.
Journal: Journal of molecular neuroscience : MN
Published: October 23, 2023
Clinical roles of EGFR amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumors.
Journal: Frontiers in neuroscience
Published: October 06, 2023
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.
Journal: Cancer medicine
Published: September 07, 2023
Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Journal: Cancer medicine
Published: April 17, 2023
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors.
Journal: Frontiers in oncology
Published: April 05, 2023
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data.
Journal: Frontiers in neurology
Published: March 08, 2023
Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors.
Journal: Frontiers in neuroscience
Published: February 14, 2023
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors.
Journal: Frontiers in neuroscience
Published: January 14, 2023
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors.
Journal: Frontiers in oncology
Published: December 25, 2022
Last Updated: 09/26/2026